Third Wave Technologies, Inc.

Other

Qiagen North American Holdings, Inc

Robert W Kwiatkowski

Sarah Olson

Marilyn C Olson-Munoz

Hon Ip

Michelle Curtis

Poonam Agarwal

Tamara J Sander

Vecheslav A Elagin

Angela Hudson

Ilse Tyler

Michelle Garsha

Michelle L Curtis

Luanne Chehak

Hatim Taysir Allawi

Hon S Ip

Wupo Ma

Sarah M Olson

Natalie E Lyamichev

Hatim T Allawi

Victor I Lyamichev

Jeff G Hall

Bruce P Neri

Peggy S Eis

Michael W Kaiser

Lin Ji

Zbigniev Skrzypczynski

Andrew A Lukowiak

LuAnne Chehak

Christian Tor Bartholomay

Tsetska Y Takova

James J Schaefer

Natalie E Lyamicheva

Kim Paulsen

WuPo Ma

John M Wages

Lisa C Thompson

Kevin L Vedvik

Robert Jackson Bair

Brad T Argue

Zbigniew Skrzypczynski

Kristen Campbell Benedict

Daniel A Strom

Wendy J Kivins

Slava Elagin

Bruce N Neri

A bowling glove includes a glove body including a palm portion configured to cover a palm of a wearer, and a protruding nub securably attachable to the palm portion of the glove body such that the location of the protruding nub relative to the palm portion of the glove body is selectively adjustable. The protruding nub is configured to protrude from the palm portion of the glove body, and the protruding nub is configured to be received by a bore of a bowling ball. A method of manufacturing the bowling glove and a method of fitting a bowling ball to the bowling glove are further described.

Bowling glove

The present invention provides compositions and methods for the detection and characterization of HPV sequences. More particularly, the present invention provides compositions, methods and kits for using invasive cleavage structure assays (e.g. the INVADER assay) to screen nucleic acid samples, e.g., from patients, for the presence of any one of a collection of HPV sequences. The present invention also provides compositions, methods and kits for screening sets of HPV sequences in a single reaction container.

Detection of HPV

The present invention provides methods, compositions, and kits for detecting the presence or absence of target sequences in a sample, where the sample also contains interfering sequences that are similar or identical to the target sequences. In particular, the present invention provides blocker oligonucleotides that at least partially inhibit the formation of invasive cleavage structures with the interfering sequences but do not substantially inhibit the formation of invasive cleavage structures with the target sequences.

Nucleic acid detection assays employing blocker oligonucleotides

The present invention provides novel cleavage agents and polymerases for the cleavage and modification of nucleic acid. The cleavage agents and polymerases find use, for example, for the detection and characterization of nucleic acid sequences and variations in nucleic acid sequences. In some embodiments, the 5' nuclease activity of a variety of enzymes is used to cleave a target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.

RNA detection assays

Growing community of inventors

Hopewell Junction, NY, United States of America

Robert W Kwiatkowski